An issue of Endo International plc – (NASDAQ:ENDP) (TSE:ENL) debt fell 1.5% against its face value during trading on Thursday. The high-yield issue of debt has a 5.75% coupon and will mature on January 15, 2022. The bonds in the issue are now trading at $85.50 and were trading at $86.94 one week ago. Price moves in a company’s debt in credit markets often anticipate parallel moves in its share price.
Several research firms recently issued reports on ENDP. BidaskClub cut shares of Endo International from a “hold” rating to a “sell” rating in a research note on Thursday. Cantor Fitzgerald set a $7.00 target price on shares of Endo International and gave the company a “hold” rating in a research note on Thursday. Mizuho restated a “buy” rating and set a $12.00 price objective (down from $14.00) on shares of Endo International in a research report on Wednesday, January 3rd. Leerink Swann began coverage on shares of Endo International in a research report on Tuesday, January 2nd. They set an “outperform” rating and a $12.00 price objective for the company. Finally, ValuEngine cut shares of Endo International from a “buy” rating to a “hold” rating in a research report on Sunday, December 31st. Three equities research analysts have rated the stock with a sell rating, fifteen have assigned a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the stock. The stock has an average rating of “Hold” and a consensus target price of $11.27.
Endo International plc – (ENDP) traded down $0.15 during trading hours on Thursday, reaching $7.92. 7,473,130 shares of the company’s stock were exchanged, compared to its average volume of 4,840,000. Endo International plc – has a 52 week low of $5.77 and a 52 week high of $15.47. The firm has a market capitalization of $1,800.00, a PE ratio of -0.41, a PEG ratio of 2.98 and a beta of 0.59. The company has a debt-to-equity ratio of 10.78, a current ratio of 1.08 and a quick ratio of 0.86.
Institutional investors have recently added to or reduced their stakes in the company. Sivik Global Healthcare LLC purchased a new stake in shares of Endo International during the second quarter worth $2,793,000. Columbia Partners L L C Investment Management purchased a new stake in shares of Endo International during the second quarter worth $1,257,000. Diamond Hill Capital Management Inc. grew its holdings in shares of Endo International by 46.8% during the third quarter. Diamond Hill Capital Management Inc. now owns 716,670 shares of the company’s stock worth $6,138,000 after buying an additional 228,426 shares in the last quarter. Parametric Portfolio Associates LLC grew its holdings in shares of Endo International by 18.7% during the second quarter. Parametric Portfolio Associates LLC now owns 398,099 shares of the company’s stock worth $4,447,000 after buying an additional 62,822 shares in the last quarter. Finally, Nationwide Fund Advisors grew its holdings in shares of Endo International by 4.9% during the second quarter. Nationwide Fund Advisors now owns 360,787 shares of the company’s stock worth $4,030,000 after buying an additional 16,913 shares in the last quarter. 93.06% of the stock is owned by institutional investors and hedge funds.
COPYRIGHT VIOLATION NOTICE: “Endo International (ENDP) Bonds Drop 1.5% During Trading” was originally reported by Markets Daily and is owned by of Markets Daily. If you are viewing this piece on another site, it was copied illegally and republished in violation of United States and international trademark and copyright laws. The correct version of this piece can be viewed at https://www.themarketsdaily.com/2018/01/12/endo-international-endp-bonds-drop-1-5-during-trading.html.
About Endo International
Endo International PLC, formerly Endo Health Solutions Inc is a specialty healthcare solutions company focused on branded and generic pharmaceuticals, devices and services. The Company has a portfolio of branded pharmaceuticals that includes brands, such as Lidoderm, Opana ER, Voltaren Gel, Percocet, Frova, Supprelin LA, Vantas, Valstar and Fortesta Gel.
Receive News & Ratings for Endo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Endo International and related companies with MarketBeat.com's FREE daily email newsletter.